NASDAQ · Medical - Care Facilities

DCGO (DCGO) Stock

$0.65 +2.91% NASDAQ: DCGO Healthcare

Valuation

MetricValue
Price$0.65
Market Cap$64.18M
P/E Ratio-0.33
P/B Ratio0.42
P/S Ratio0.20
EPS (TTM)$0.00
52-Week High$1.78
52-Week Low$0.46
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-126.39%
ROA-83.87%
ROCE-70.63%
Gross Margin-27.64%
Operating Margin-27.64%
Net Margin-62.23%
Debt/Equity0.22
Current Ratio2.27

Annual Financials (USD)

Metric20212022202320242025
Revenue$319.0M$441.0M$624.0M$617.0M$322.0M
Operating Profit$15.0M$22.0M$15.0M$29.0M$-89.0M
Net Profit$24.0M$35.0M$7.0M$20.0M$-182.0M
EPS$0.25$0.34$0.06$0.18$-1.84
Op Margin4.8%5.0%2.4%4.7%-27.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$310.0M$393.0M$490.0M$456.0M$217.0M
Total Liabilities$83.0M$114.0M$185.0M$140.0M$91.0M
Cash$176.0M$157.0M$59.0M$89.0M$51.0M
Borrowings$17.0M$20.0M$46.0M$57.0M$29.0M

Latest News

DocGo Launches Mobile Phlebotomy Services in South Florida Business Wire · Jun 3, 2026 How The DocGo (DCGO) Story Is Shifting As Transport Optimism Meets Lower Valuation Targets Simply Wall St. · May 16, 2026 DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport MarketBeat · May 16, 2026 US$1.87: That's What Analysts Think DocGo Inc. (NASDAQ:DCGO) Is Worth After Its Latest Results Simply Wall St. · May 14, 2026 DocGo Inc (DCGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges GuruFocus.com · May 12, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$29.0M$-64.0M$70.0M$34.0M
Investing Cash Flow$-15.0M$-44.0M$-40.0M$-17.0M$-47.0M
Financing Cash Flow$-20.0M$-2.0M$-21.0M$1.29T$-16.0M
Net Cash Flow$145.0M$-15.0M$-92.0M$35.0M$-55.0M
Free Cash Flow$-9.0M$23.0M$-74.0M$65.0M$27.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA
FCF Yield-8560781.74%
Quick Ratio1.79
Interest Coverage-89.00
Return 1Y-52.24%
Return 3Y-92.80%
Return 5Y-93.29%

Ownership

Insiders Held3.07%
Institutions Held43.52%
Institutions Float Held44.90%
Institutional HolderSharesReport Date
Blackrock Inc.6,366,0282026-03-31
Vanguard Capital Management LLC3,682,5682026-03-31
P.A.W. Capital Corp3,000,0002026-03-31
Knott David M., Jr.2,670,8502026-03-31
Citadel Advisors Llc2,500,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
COYA $4.00 -6.21% -2.62 $72.84M 0.00%
IMMX $8.55 +4.65% -9.96 $465.14M 0.00%
MBOT $1.68 -3.45% -6.38 $76.56M 0.00%
MGNX $3.78 +3.00% -2.92 $240.27M 0.00%
NSPR $0.69 +0.87% -1.21 $32.30M 0.00%

About DCGO

DCGO is led by CEO Lee Bienstock, employs 3,404 people, headquartered in US, publicly traded since 2020.

DCGO stock trades at $0.65 with a market capitalization of $64.18M. The stock is valued at a price-to-earnings (P/E) ratio of -0.33, price-to-book of 0.42, price-to-sales of 0.20. Over the past 52 weeks the stock has ranged between $0.46 and $1.78, and currently trades 63.5% below its 52-week high.

On profitability, DCGO generates a return on equity (ROE) of -126.39%, return on capital employed of -70.63%, an operating margin of -27.64%, a net profit margin of -62.23%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides